Can Fite Biopharma (STU:CF5) General and Admin. Expense: €3.15 Mil (TTM As of Dec. 2025)


STU:CF5 Can Fite Biopharma Ltd STU:CF5
52 GF Score
Price €101.00
GF Value €163.41
! 4 Warning Signs
View Full Analysis

What is Can Fite Biopharma General and Admin. Expense?

Can Fite Biopharma STU:CF5 52 General and Admin. Expense is €3.15 Mil as of Dec. 2025. GuruFocus rates STU:CF5 with a GF Score™ of 52/100 and a GF Value™ of €163.41. The stock has 4 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Can Fite Biopharma's General and Admin. Expense for the six months ended in Dec. 2025 was €1.36 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €3.15 Mil.

Can Fite Biopharma General and Admin. Expense Related Terms

Can Fite Biopharma General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Can Fite Biopharma's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Can Fite Biopharma General and Admin. Expense Chart

Can Fite Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.40 2.97 2.71 2.91 3.13

Can Fite Biopharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.36 1.42 1.45 1.79 1.36
STU:CF5
52GF Score
Can Fite Biopharma Ltd STU:CF5
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Can Fite Biopharma General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of €3.15 Mil mean?
Can Fite Biopharma (STU:CF5) has a General and Admin. Expense of €3.15 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Can Fite Biopharma and its competitors.
Is Can Fite Biopharma's General and Admin. Expense too high?
Can Fite Biopharma's current General and Admin. Expense is €3.15 Mil. Overall, Can Fite Biopharma has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Can Fite Biopharma's General and Admin. Expense compare to VRTX and REGN?
Can Fite Biopharma's General and Admin. Expense of €3.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Can Fite Biopharma and its competitors. Can Fite Biopharma's current General and Admin. Expense is €3.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Can Fite Biopharma stock overvalued right now?
Can Fite Biopharma (STU:CF5) has a current General and Admin. Expense of €3.15 Mil. The stock's GF Value™ is €163.41, compared to a current price of €101.00 — trading 38.2% below its estimated fair value. The current General and Admin. Expense is €3.15 Mil. Can Fite Biopharma's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Can Fite Biopharma (STU:CF5), the current General and Admin. Expense is €3.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Can Fite Biopharma (STU:CF5) Overvalued in 2026?

Based on GuruFocus' analysis, Can Fite Biopharma stock appears to be undervalued. The current stock price of €101.00 is trading 38.2% below its estimated GF Value™ of €163.41.

Key valuation signals for STU:CF5:

  • General and Admin. Expense: €3.15 Mil
  • GF Value™: €163.41 vs. price of €101.00 (38.2% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the STU:CF5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Can Fite Biopharma Business Description

Other Exchanges CANF:USACANF:Israel
Address 26 Ben Gurion Street, Ramat Gan, ISR, 5257346
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
52GF Score

Get the complete analysis for STU:CF5

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€101.00
Price
€163.41
GF Value